Published in Arch Neurol on July 01, 2007
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement (2011) 1.81
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Born to choose: the origins and value of the need for control. Trends Cogn Sci (2010) 1.51
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain (2009) 1.50
A review of neuroimaging findings of apathy in Alzheimer's disease. Int Psychogeriatr (2013) 1.39
Behavioral and psychological symptoms of dementia. Front Neurol (2012) 1.34
Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord (2012) 1.07
Posttraumatic stress disorder: a theoretical model of the hyperarousal subtype. Front Psychiatry (2014) 0.92
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry (2009) 0.89
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev (2012) 0.89
Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat (2013) 0.89
Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry (2013) 0.87
Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain (2015) 0.86
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease. Neurosci Biobehav Rev (2014) 0.86
Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response. J Affect Disord (2014) 0.85
Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. J Neuropsychiatry Clin Neurosci (2012) 0.85
Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci (2013) 0.83
Different apathy profile in behavioral variant of frontotemporal dementia and Alzheimer's disease: a preliminary investigation. Curr Gerontol Geriatr Res (2012) 0.82
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. Int J Nanomedicine (2015) 0.81
Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci (2014) 0.80
Strategic lesions in the anterior thalamic radiation and apathy in early Alzheimer's disease. PLoS One (2015) 0.79
Frontostriatal cognitive staging in Parkinson's disease. Parkinsons Dis (2011) 0.79
FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. J Alzheimers Dis (2016) 0.78
Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults. Aging Ment Health (2013) 0.78
Stereotypic behaviors in degenerative dementias. J Neurol (2012) 0.77
Structural differences of amyloid-β fibrils revealed by antibodies from phage display. BMC Biotechnol (2015) 0.76
Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment. J Alzheimers Dis (2015) 0.76
Cognition and dual-task performance in older adults with Parkinson's and Alzheimer's disease. Int J Gen Med (2014) 0.75
Apathy and intrinsic functional connectivity networks in amnestic mild cognitive impairment. Neuropsychiatr Dis Treat (2016) 0.75
Apathy and olfactory dysfunction in early Parkinson's disease. J Mov Disord (2015) 0.75
Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment. Brain Behav (2017) 0.75
Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder. J Neuropsychiatry Clin Neurosci (2016) 0.75
Prefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy Subjects. PLoS One (2016) 0.75
Neural correlates of apathy in late-life depression: a pilot [(18) F]FDDNP positron emission tomography study. Psychogeriatrics (2017) 0.75
The Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity-A Functional MRI Study in the Awake Rat. Front Pharmacol (2017) 0.75
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Mild cognitive impairment. Lancet (2006) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2012) 4.22
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2002) 3.26
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology (2003) 2.32
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging (2004) 2.23
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci (2007) 2.14
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry (2003) 2.07
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain (2007) 1.99
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol (2003) 1.93
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry (2003) 1.86
A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res (2005) 1.85
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry (2003) 1.83
Effective pharmacologic management of Alzheimer's disease. Am J Med (2007) 1.79
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70
The neural correlates of placebo effects: a disruption account. Neuroimage (2004) 1.68
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord (2007) 1.61
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis (2010) 1.57
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol (2007) 1.55
Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord (2004) 1.53
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Frontal lobe hypometabolism and impaired insight in Alzheimer disease. Am J Geriatr Psychiatry (2005) 1.51
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp (2010) 1.40
Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement (2008) 1.39
Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry (2005) 1.38
Dementia with parkinsonism: what is the diagnosis? Rev Neurol Dis (2004) 1.38
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A (2006) 1.34
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial. Schizophr Bull (2003) 1.32
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics (2006) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci (2002) 1.30
Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci (2003) 1.27
Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.25
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci (2004) 1.23
Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry (2006) 1.22
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol (2009) 1.17
Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach. Alzheimers Dement (2006) 1.16
The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. J Sleep Res (2003) 1.15
Frontal-subcortical dementias. Neurologist (2008) 1.14
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Neuropsychiatric symptoms in the dementias. Curr Opin Neurol (2002) 1.13
Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med (2004) 1.12
The role of cognitive impairment and caregiver support in diabetes management of older outpatients. Int J Psychiatry Med (2009) 1.07
3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 1.06
Early-onset Alzheimer's disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol (2007) 1.05
Apathy and executive function in Alzheimer's disease. J Int Neuropsychol Soc (2002) 1.05
Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology (2002) 1.05
3D mapping of language networks in clinical and pre-clinical Alzheimer's disease. Brain Lang (2007) 1.05
Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. J Am Geriatr Soc (2003) 1.04
Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord (2014) 1.03
The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. J Behav Med (2011) 1.03
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2012) 1.02
Neuropathologic correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 1.02
Toward a more precise, clinically--informed pathophysiology of pathological laughing and crying. Neurosci Biobehav Rev (2013) 1.01
Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord (2010) 1.01
Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 1.00
Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother (2010) 0.99
Relative tolerability of Alzheimer's disease treatments. Psychiatry (Edgmont) (2008) 0.99
Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease. Dement Geriatr Cogn Disord (2012) 0.99
Current and emerging pharmacological treatment options for dementia. Behav Neurol (2006) 0.98
Association of GSK3B with Alzheimer disease and frontotemporal dementia. Arch Neurol (2008) 0.98
Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts. Am J Geriatr Psychiatry (2013) 0.97
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Arch Neurol (2012) 0.97
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Arch Neurol (2005) 0.97
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry (2008) 0.96
Speech and language in progressive nonfluent aphasia compared with early Alzheimer's disease. Neurology (2003) 0.96
Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. Am J Alzheimers Dis Other Demen (2006) 0.96
Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol (2005) 0.94
Differences in anxiety among patients with early- versus late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2014) 0.94
The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study. Int J Geriatr Psychiatry (2009) 0.94
Executive dysfunction in Alzheimer disease. Arch Neurol (2004) 0.94
Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol (2004) 0.94
Clinical trials in predementia stages of Alzheimer disease. Med Clin North Am (2013) 0.94
Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications. Neurobiol Aging (2012) 0.93
Idiopathic pulmonary fibrosis: evaluation with positron emission tomography. Respiration (2005) 0.92
Content-specific delusions from right caudate lacunar stroke: association with prefrontal hypometabolism. J Neuropsychiatry Clin Neurosci (2008) 0.92
Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. J Neuropsychiatry Clin Neurosci (2005) 0.92
Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 0.92
Deficits in facial emotion processing in mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 0.91
Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI). J Geriatr Psychiatry Neurol (2004) 0.91
Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Curr Alzheimer Res (2009) 0.91
Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task. Cereb Cortex (2010) 0.91